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To study the impact of maternal country of birth on type-1-diabetes (T1D) therapy and
outcome.
Study Design and Methods
27,643 T1D patients aged20 years with documented maternal country of birth from the
multicenter German/Austrian diabetes patient registry (DPV) were analyzed. Patients were
categorized based on their mother’s origin: Germany/Austria (reference), Turkey, Southern
Europe, and Eastern Europe. To compare BMI standard deviation score (BMI-SDS), diabe-
tes therapy and outcome between groups, multivariable regression was applied with adjust-
ments for age, sex and duration of diabetes. Based on observed marginal frequencies,
adjusted estimates were calculated. Linear regression was used for continuous data, logis-
tic regression for binary data and Poisson regression for count data. All statistical analyses
were performed using SAS 9.4. Significance was set at a two-tailed p<0.05.
Results
83.3% of patients were offspring of native mothers. A Turkish, Southern or Eastern Euro-
pean background was documented in 2.4%, 1.7% and 4.3% of individuals. After
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demographic adjustment, patients with migration background had a higher mean BMI-SDS
(Turkey, Southern Europe or Eastern Europe vs. Germany/Austria: 0.58±0.03, 0.40±0.04,
or 0.37±0.02 vs. 0.31±0.01; ±SE) and a lower use of insulin pumps (26.8%, 27.9%, or
32.6% vs. 37.9%) compared to offspring of native mothers. Mean HbA1c was worst in indi-
viduals of Turkish mothers (Turkey vs. Germany/Austria: 69.7±0.7 vs. 66.6±0.1 mmol/mol;
±SE). Patients of Eastern European descent had an increased rate of severe hypoglycemia
(22.09±0.13 vs. 16.13±0.02 events per 100 patient-years) and ketoacidosis was more prev-
alent in offspring of Turkish or Southern European mothers (7.50±0.10, or 7.13±0.11 vs.
6.54±0.02 events per 100 patient-years). Patients of Turkish descent were more often hos-
pitalized (57.2±2.7 vs. 48.5±0.4 per 100 patient-years). All differences were significant.
Conclusion
The differences in diabetes therapy and outcome among patients with distinct migration
background suggest that specific challenges have to be considered in clinical care.
Introduction
Type-1-diabetes (T1D) is the most common chronic metabolic disease in childhood and ado-
lescence. In Germany, approximately 30,000 children and adolescents are affected [1]. A very
large number of studies revealed an association between migration and poor health status in
T1D [2–6]. However, health status varies widely among ethnicities and depends on the country
of origin [7]. In Germany, about one quarter of children and adolescents under the age of 18
years has a migration background and people of Turkish descent are the largest migrant popu-
lation [7]. Nowadays, the majority (80%) of migrant children and adolescents is born in Ger-
many and are second- or third-generation descendants of immigrants [7].
With rising cultural diversity, challenges in daily life and health care occur [8]. It is known
that with longer duration of stay immigrants tend to adopt living habits, health concepts and
health-related behavior of the new country [9,10]. However, their health status may worsen
due to a lower socio-economic status or migration stress [9,10]. In people with migration back-
ground, cultural or religious differences, different health belief or self-care behavior and a
lower adherence to treatment regimens compared to the native population were also described
and may additionally contribute to a worse health outcome [3,4,11]. Even though a recent
Canadian study found no increased rate of diabetes complications in immigrants with language
barriers [12], communication problems have been also reported to result in difficulties during
routine care [4]. Lower health literacy skills, that mean a lower ability to gather, understand
and apply health information in order to make adequate judgements and decisions in health-
care and to adhere to treatment recommendations [13], might be an additional contributor to
a worse health status in immigrants compared to the native population [14]. Furthermore,
nutritional and lifestyle habits differ between ethnicities and cultural knowledge is often lacking
in health care professionals [8]. As known for obesity and T1D incidence [15,16], a genetic
component has also been reported to play a role in glycemic control and the occurrence of dia-
betes-related complications, mainly retinopathy and nephropathy [16,17]. Thereby, differences
in health outcome can also partially be attributed to specific genomic loci that influence disease
susceptibility and differ between certain population groups [16,17].
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There are several studies reporting a poor glycemic control, a higher rate of hospitalization,
hypoglycemia or ketoacidosis, and finally an increased risk for late diabetes-related complica-
tions and mortality in patients with migrant background [3–6,18]. By contrast, in the Hvidoere
study [4], patients with language difficulties had no increased frequency of diabetic ketoacido-
sis or hypoglycemia. Due to the inconsistent definitions and concepts of ethnicity or migrant
background between populations and studies [19], a direct comparison is often difficult and a
transfer from findings in foreign countries to the own country is not possible. In particular for
children of immigrants, a higher hemoglobin A1c (HbA1c) and a lower use of insulin pumps
compared to children of native mothers have been reported [20]. As lack of parental support
has been associated with higher HbA1c [21], potential cultural discrepancies for parental
involvement in diabetes management may also contribute to differences in children’s health
outcome. Differences in usage of and access to pump therapy or high-quality medical care were
discussed as potential reasons for the lower use of insulin pumps in migrant groups [22]. In
children, daily diabetes management is usually supervised by mothers rather than fathers, and
mostly mothers are the ones caring for the child [23].
The primary aim of this study was to investigate the influence of maternal country of birth
on T1D therapy and outcome in 27,643 patients aged 20 years or younger. Contrary to many
previous studies, this research differentiates between regions of origin, as individuals with
migration background are not a homogenous group.
Methods
Ethics statement
The DPV initiative has been approved by the Ethical Committee of the Medical Faculty of the
University of Ulm, Germany and the anonymized data collection by the local review board of
each participating center.
Patients and data collection
Data from the multicenter, standardized, prospective diabetes patient registry, DPV, was used
for the present study (www.d-p-v.eu). Over a period of nearly 20 years, specialized diabetes
care centers all over Germany and Austria have been documenting patient characteristics and
diabetes-specific data regularly in an electronic health record system. Semi-annually, the locally
documented data is transferred in anonymous form to Ulm University, Germany. After plausi-
bility checks and corrections, the data is aggregated into a cumulative database, the DPV regis-
try. It covers an estimated proportion of>80% of all pediatric patients diagnosed with diabetes
in Germany and Austria [24].
For the present study,20 year-old patients with T1D onset between>6 months and18
years and at least 2 years of diabetes were included (Fig 1). Further inclusion criteria were: doc-
umented visits between 2000 and 2013, and information on maternal country of birth. Patients
with mothers born outside Germany/Austria, Turkey, Southern or Eastern Europe were
excluded due to the small number of cases per country. Finally, 27,643 T1D patients were eligi-
ble for the study (Fig 1). The most recent treatment year of each patient was analyzed. In case
of multiple datasets per patient, quantitative parameters were aggregated as median and count
data as cumulative sums.
Definition of migration status
Migration status was defined based on maternal country of birth. The study population was
categorized into four groups according to patient’s maternal origin: i) Germany/Austria (native
Maternal Country of Birth and Type-1-Diabetes
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mothers; reference), ii) Turkey, iii) Southern Europe, and iv) Eastern Europe. The definitions
for Southern and Eastern Europe were primarily based on geographic criteria [25], modified by
economic and cultural aspects. Southern Europe comprised Albania, Andorra, Gibraltar,
Greece, Vatican City State, Italy, Malta, Portugal, San Marino, Spain, former Yugoslavia, and
excluded Turkey. Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia and the
countries of the former Soviet Union formed Eastern Europe.
Anthropometry
Body mass index standard deviation score (BMI-SDS) was computed by using national refer-
ence data from the German Health Interview and Examination Survey for Children and
Fig 1. Selection of study population.
doi:10.1371/journal.pone.0135178.g001
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Adolescents (KiGGS, Robert Koch-Institute, Berlin, Germany) [26]. For patients aged>18
years, data was extrapolated by using L-, M- and S-values of 18 year-old people. In the KiGGS
study, 17% of all participants had a migration background [26].
Glycemic control
Glycemic control was assessed by median HbA1c. The multiple of the mean method was
applied to mathematically harmonize HbA1c values to the Diabetes Control and Complica-
tions Trial reference range (20.7–42.6 mmol/mol; 4.05–6.05%) [6,27].
Diabetes therapy
Insulin treatment was categorized as conventional injection therapy using syringes/pens (1–8
injection time-points/day) and insulin pump therapy. Daily insulin dosage per kilogram body
weight was calculated and the number of injection time-points per day was analyzed by using
the definition that insulin pump therapy equals 9 injection time-points per day. Daily fre-
quency of self-monitoring of blood glucose (SMBG) was evaluated.
Acute diabetes-related complications
If patients required assistance of another person during an episode of hypoglycemia to admin-
ister carbohydrates or glucagon, the event was specified as severe hypoglycemia. Diabetic
ketoacidosis (DKA) was defined as either a blood pH value<7.3, or as a clinician-based diag-
nosis of diabetic ketoacidosis associated with hospitalization.
Chronic diabetes-related complications
Hypertension was classified as an elevated median systolic or diastolic blood pressure95th
percentile for age, sex and height and/or the use of anti-hypertensive medication. Reference
values for normative blood pressure were retrieved from the KiGGS study [28]. In patients
aged>18 years, values were extrapolated. Dyslipidemia was classified as the use of lipid-lower-
ing medication and/or at least one lipid parameter on average above/below the following
thresholds: total cholesterol>5.2 mmol/l, triglycerides>1.7 mmol/l, LDL>3.4 mmol/l, HDL
<0.9 mmol/l [29]. Microalbuminuria was assessed by urinary albumin excretion. In line with
the American Diabetes Association (ADA) guidelines, a value of30 mg/24 h (20 μg/min on
a timed sample or30mg/g creatinine on a random collection) in at least two of three tests
was defined as microalbuminuria [30]. As clinical manifestation of micro- and macrovascular
complications of diabetes are uncommon in childhood and adolescence [31], further chronic
diabetes-related complications like retinopathy, stroke, myocardial infarction or diabetic foot
syndrome could not be analyzed in our group of pediatric patients.
Patient care
To specify patient care, the rate of hospitalization and the duration of hospital stay were stud-
ied. Moreover, the number of outpatient visits was analyzed.
Statistical analysis
Results of descriptive statistics are displayed as median with quartiles or as proportion. As
non-normally distributed data was assumed, Kruskal-Wallis test was used to compare continu-
ous parameters and χ2-test was applied for dichotomous variables.
Due to differences in demographics between patients with migration background and native
patients, multivariable regression models were created to compare BMI-SDS, diabetes therapy
Maternal Country of Birth and Type-1-Diabetes
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and outcome. Adjustments were made for the following demographics: age, sex and duration
of diabetes. Based on observed marginal frequencies, adjusted estimates were calculated. Linear
regression was applied for continuous data and logistic regression for binary data. Count data
was compared by Poisson regression. As estimation technique, residual pseudo-likelihood with
a subject-specific expansion (rspl) was used in linear regression and maximum pseudo-likeli-
hood with marginal expansion (mmpl) in logistic or Poisson regression. To investigate whether
paternal influence on diabetes management is similar to that of the mother, the analyses were
repeated after categorizing patients by their father’s origin of birth (Germany/Austria:
n = 24,948, Turkey: n = 788, Southern Europe: n = 599, Eastern Europe: n = 1,122, unknown:
n = 186).
SAS version 9.4 (Statistical Analysis Software, SAS Institute Inc., Cary, NC, USA) was used
for statistical analysis. Significance was set at a two-tailed p<0.05.
Results
Description of study population
Median age of the 27,643 patients (48.1% girls) eligible for the study was 15.7 [12.4; 17.6] years
and median duration of diabetes amounted to 6.3 [4.0; 9.4] years. 83.3% (n = 25,107) of
patients studied had a mother born in Germany or Austria. A Turkish or Southern European,
or Eastern European background was documented in 2.4% (n = 736), 1.7% (n = 517) and 4.3%
(n = 1,283) of individuals. In group-specific analysis, median age and duration of diabetes was
higher in patients of native mothers compared to offspring of non-native mothers (Germany/
Austria vs. Turkey, Southern or Eastern Europe; age in years: 15.7 [12.5; 17.5] vs. 14.8 [12.1;
17.4], 14.4 [10.9; 17.0], or 14.3 [11.0; 17.1], each p<0.001; duration of diabetes in years: 6.4
[4.0; 9.4] vs. 5.8 [3.7; 8.8], 5.9 [3.9; 9.1], or 5.6 [3.7; 8.3], each p<0.001). Proportion of girls did
not differ significantly between groups (47.8 vs. 52.3, 49.3, or 49.4%).
Anthropometry
BMI-SDS values of native and non-native children after adjustment for age, sex and duration
of diabetes are summarized in Fig 2A. Compared to offspring of native mothers, patients with
Turkish, Southern European, or Eastern European migrant background revealed a significantly
higher BMI-SDS.
Glycemic control
Fig 2B depicts glycemic control assessed by HbA1c for children of non-native mothers com-
pared to offspring of native mothers after adjustment for age, sex and duration of diabetes.
Descendants of Turkish mothers had a worse glycemic control compared to offspring of native
mothers (Fig 2B). By contrast, in patients of mothers from Southern or Eastern Europe, no dif-
ference could be observed compared to offspring of native mothers (Fig 2B).
Diabetes therapy
Data on insulin therapy are summarized in Table 1 and are adjusted for age, sex and duration
of diabetes. The use of insulin pumps was less common and the number of injection time-
points per day was lower in patients with migration background, irrespective of region of origin
(Table 1). By contrast, insulin dosage per kilogram body weight and the daily number of
SMBG measurements did not differ clinically relevant between groups (Table 1).
Maternal Country of Birth and Type-1-Diabetes
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Acute diabetes-related complications
Table 1 depicts also information on hypoglycemia and diabetic ketoacidosis after adjustment
for age, sex and duration of diabetes. Severe hypoglycemia was more common in patients of
Eastern European descent compared to offspring of native mothers. By contrast, no clinically
relevant difference in the occurrence of severe hypoglycemia was observed between offspring
of Turkish or Southern European mothers and patients of native mothers. Diabetic ketoacido-
sis was more frequent in descendants of Turkish or Southern European mothers, whereas in
Fig 2. BMI-SDS (A) and glycemic control (B) in type-1-diabetes, depending onmaternal (left bar) or
paternal (right bar) country of birth.G/A Germany/Austria (white bar), TR Turkey (hashed bar), SE
Southern Europe (black bar), EE Eastern Europe (dotted bar), *p<0.05, **p<0.001. Given are adjusted
estimates (±SE) based on multivariable regression modeling. Adjustments were made for age, sex and
duration of diabetes. To convert HbA1c in %: (mmol/mol-value 10.929) + 2.15.
doi:10.1371/journal.pone.0135178.g002
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offspring of Eastern European mothers the rate was slightly lower compared to children of
native mothers.
Chronic diabetes-related complications
Results of chronic diabetes complications after adjustment for age, sex and duration of diabetes
are summarized in Table 1. Compared to offspring of native mothers, hypertension was more
frequent in patients with Turkish or Eastern European background and tended to be less com-
mon in individuals of Southern European descent (Table 1). Dyslipidemia occurred less fre-
quently in offspring of Southern European mothers and revealed a tendency towards a higher
rate in offspring of Turkish mothers (Table 1). Between patients with Eastern European back-
ground and individuals of native mothers, the frequency of dyslipidemia was comparable
Table 1. Diabetes therapy and outcome in type-1-diabetes patients aged20 years, depending onmaternal country of birth.













N 25,107 736 517 1,283
Diabetes therapy
Insulin pumps, % 37.9 26.8 <0.001 27.9 <0.001 32.6 <0.001
Injection time-points, per day 6.48±0.01 5.87±0.08 <0.001 5.97±0.09 <0.001 6.28±0.06 0.002
(n = 24,770) (n = 730) (n = 514) (n = 1,276)
Insulin dosage, IU/kg*d 1.037±0.002 1.054
±0.012
ns 1.033±0.014 ns 1.057±0.009 0.035
(n = 24,770) (n = 730) (n = 514) (n = 1,276)
SMBG, per day 5.88±0.01 5.72±0.08 ns 5.57±0.10 0.002 5.81±0.06 ns
(n = 23,473) (n = 717) (n = 498) (n = 1,244)
Acute diabetes
complications




<0.001 14.83±0.16 <0.001 22.09±0.13 <0.001
DKA, per 100 pat.years 6.54±0.02 7.50±0.10 <0.001 7.13±0.11 <0.001 6.20±0.07 <0.001
Chronic diabetes
complications
Hypertension, % 28.3 32.0 0.030 26.5 ns 32.0 0.005
(n = 24,358) (n = 729) (n = 509) (n = 1,252)
Dyslipidemia, % 39.9 44.1 ns 33.7 0.016 41.2 ns
(n = 19,380) (n = 560) (n = 384) (n = 1,019)
Microalbuminuria, % 12.0 14.1 ns 11.9 ns 11.3 ns
(n = 18,243) (n = 558) (n = 370) (n = 999)
Patient care
Hospitalization, per 100 pat.
years
48.5±0.4 57.2±2.7 <0.001 46.7±2.9 ns 52.0±1.9 ns
Duration of hospital stay,
days per 100 pat.years
441±1 433±7 ns 355±8 <0.001 427±5 0.019
Outpatient visits, per 100 pat.
years
388±1 416±7 <0.001 392±9 ns 396±6 ns
(n = 22,124) (n = 685) (n = 471) (n = 1,161)
Based on multivariable regression, adjusted estimates (±SE) were calculated. Adjustments were made for age, sex, duration of diabetes. P-values are
given for the comparison between people of native mothers (Germany/Austria) and offspring of mothers born in Turkey, Southern Europe or Eastern
Europe. Abbreviations: DKA diabetic ketoacidosis, ns not signiﬁcant, pat.years patient-years, SMBG self-monitoring of blood glucose.
doi:10.1371/journal.pone.0135178.t001
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(Table 1). Regarding the presence of microalbuminuria, no statistically significant difference
could be found between groups (Table 1). However, a trend towards a higher frequency of
microalbuminuria in children of Turkish mothers compared to offspring of native mothers
could be observed (Table 1).
Patient care
As presented in Table 1, the rate of hospitalization and the number of outpatient visits were
higher in patients of Turkish descent, but comparable between offspring of Southern or Eastern
European mothers and individuals of native mothers after adjustment for age, sex and duration
of diabetes. Moreover, the duration of hospital stay was shortest in patients of Southern Euro-
pean descent, whereas no relevant difference could be observed between the other groups
(Table 1).
Impact of paternal country of birth
Table 2 summarizes the various combinations of maternal and paternal origin of birth. As indi-
cated by bold-typed figures, the majority of the parents came from the same country.
Repeating the analyses after categorizing individuals based on their paternal country of
birth did not change our findings, except for dyslipidemia and insulin dosage. In contrast to
the analysis of maternal migrant status, the non-significantly higher prevalence of dyslipidemia
in individuals with Turkish background reached significance in the analysis of paternal migrant
status (43.9% vs. 39.8%, p = 0.045). Furthermore, the significant difference in daily insulin dos-
age between children of Eastern European descent and native mothers lacked significance in
the analysis of paternal migrant status (1.053±0.010 vs. 1.036±0.002 IU/kgd, p = 0.099).
Discussion
This large, multicenter study among T1D patients aged 20 years or younger revealed differences
in diabetes therapy and outcome between patients with and without migration background, but
also specific disparities among the three migrant groups studied. Besides a higher BMI-SDS and
a lower frequency of insulin pump therapy in offspring with migrant background, differences in
specific areas of diabetes therapy and outcome were observed depending on the region of origin.
Table 2. Cross-classified table for parental country of birth.
Paternal country of birth Total
Maternal country of birth, n/% Germany/Austria Turkey Southern Europe Eastern Europe Unknown
Germany/Austria 24,631 89 161 78 148 25,107
98.1% 0.4% 0.6% 0.3% 0.6% 100%
Turkey 45 688 0 0 3 736
6.1% 93.5% 0.0% 0.0% 0.4% 100%
Southern Europe 84 1 420 3 9 517
16.2% 0.2% 81.2% 0.6% 1.8% 100%
Eastern Europe 188 10 18 1,041 26 1,283
14.7% 0.8% 1.4% 81.1% 2.0% 100%
Total, n/% 24,948 788 599 1,122 186 27,643
90.3% 2.8% 2.2% 4.0% 0.7% 100%
Data are given as absolute values (ﬁrst line) and row percentages (second line). Bold-typed ﬁgures indicate that parents were from the same country. Of
186 patients, paternal origin of birth was unknown or not documented.
doi:10.1371/journal.pone.0135178.t002
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It seems that existing diabetes care structures do not adequately reach all patients with migrant
background and should be modified in terms of diversity management.
The higher BMI-SDS in patients with migration background compared to offspring of non-
migrants is in line with another German study indicating an increase in BMI among immi-
grants with longer duration of residence [32]. Several potential reasons are given in the intro-
duction section. Moreover, cultural differences in the consumption of daily foods might be a
further explanation. A representative German study reported for children with Turkish back-
ground a higher intake of soft drinks, white bread, chocolate and snacks compared to non-
migrants [33]. Moreover, Russian migrants ate the highest amount of sausage and bacon [33].
The ideal body shape is assumed to be culture-sensitive [34] and thereby may also account for
different BMI values between populations. Genetic differences between ethnicities may also
play a role [15]. Recently, the ADA proposed the use of an Asian American-specific BMI cut-
off for diabetes screening [35].
In our study, glycemic control was worse in patients of Turkish descent. Most research
reported also a lower HbA1c in the respective native population than in minority groups
[6,36]. A lower frequency of insulin injection time-points as observed by our study might be
one explanation. For non-Scandinavian children, a lower number of bolus insulin injections
and a slightly higher HbA1c compared to children of Scandinavian mothers had been reported
[20]. When interpreting our results, physiological and biological differences between ethnic
groups should also be considered (e.g. differences in red blood cell turnover, biological factors
influencing non-enzymatic glycation or enzymatic deglycation of HbA1c independent of mean
blood glucose [36]).
The results of our study suggest that diabetes outcome varies depending on type of migration
background. For example, most diabetes complications were more prevalent in patients of Turk-
ish mothers, whereas in people of Southern or Eastern European descent solely specific differ-
ences compared to offspring of native mothers were observed. A combination of different
factors and a potentially inadequate adaption of existing care structures to the needs and risks of
patients with migrant background are suspected to cause higher rates of diabetic ketoacidosis
and hypoglycemia in some groups of migrants. Besides the previously mentioned reasons, the
higher rate of hypoglycemia in patients with Eastern European background might be due to dif-
ferences in eating and may be drinking patterns (e.g. higher intake of calories from fat, or higher
consumption of alcohol with more irregular heavy drinking episodes [37]). As shown recently,
there is no longer an inverse association between HbA1c and the risk of hypoglycemia [24].
Our findings confirm other studies suggesting a higher prevalence of hypertension and a
more unfavorable lipid profile in people of Turkish origin [38,39]. The lower prevalence of dys-
lipidemia in individuals of Southern European descent is not surprising and might be related
to differences in LDL receptor activity.
As indicated by a preliminary report focusing on the access to insulin pumps in patients
with Turkish origin [22] and reported also for children of non-Scandinavian mothers [20], a
less frequent use of insulin pumps was observed in offspring of non-native parents; with the
lowest prevalence in patients with Turkish background followed by offspring of Southern
European mothers and people of Eastern European descent. Unlike other health care services
in Germany and Austria, the costs of insulin pump therapy are not automatically covered by
the statutory health insurances. Each patient has to apply individually for reimbursement. Dif-
ferences in approval of reimbursement between patients with and without migration back-
ground cannot be completely excluded, as poor integration and discrimination of migrants is
still present [10]. Moreover, insulin pump therapy is more complex and requires a higher com-
petence for self-management than conventional injection therapy [40]. All together may con-
tribute to a lower use of insulin pumps in patients with migrant background. On the other
Maternal Country of Birth and Type-1-Diabetes
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hand, a lower education, a potentially lower rate of acceptance for pump therapy or new tech-
niques and a possible lack of knowledge about health care offers might be further reasons.
Contrary to previous assumptions of a higher rate of hospitalization and a longer duration
of stay in patients with migrant background [41], no major difference was observed between
patients of native and non-native mothers. Although limitations in diabetes care for undocu-
mented immigrant patients should be kept in mind, this is likely due to the highly standardized
diabetes care in Germany and Austria. The only exception was the significantly higher rate of
hospitalization and the higher number of outpatient visits in people of Turkish descent which
may be related to the higher HbA1c and thus to more acute complications requiring hospital
care (e.g. diabetic ketoacidosis).
Overall, the relatively small differences between patients with and without migration back-
ground found in our study compared to reports from other countries might be related to the
statutory health insurance system existing in Germany and Austria that covers the majority of
health care costs. Contrary to e.g. the US, access to health care services is not limited by differ-
entials in insurance coverage.
Major strengths of the present study are the large number of patients included and the dif-
ferentiation between regions of origin, as people with migrant background are not a homoge-
nous group. One limitation is that migration status was defined by parental country of birth.
Thus, patients of the “third generation” born in Germany or Austria to parents with a migra-
tion background were classified as offspring of native parents. Unfortunately, we could not
analyze some of the individual-level variables e.g. parental support or patient satisfaction with
insulin pumps that might explain the disparities between patients with and without migration
background. Moreover, in several studies, differences attributed to migration background dis-
appeared after adjustment for socio-economic status.
In conclusion, there is considerable heterogeneity in diabetes outcome among patients with
migration background, but the differences between people with and without migrant back-
ground seem to be less pronounced in Germany and Austria than in other countries like the
US or Canada. Nevertheless, in the future reasons contributing to differences in diabetes out-
come should be investigated in order to tailor existing care structures to needs and risks of each
individual patient irrespective of migrant background.
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